BCBS Arizona Medical Policy Updates – August 2018

Click here to view the Arizona Blue Cross Blue Shield Medical Policy Updates »

 August 2018 Medical Policy Updates:

• Annular Repair
• Aqueous Shunts and Stents for the Treatment of Glaucoma
• Autism Spectrum Disorder Treatments
• Beds, Air Fluidized
• Bio-Engineered Skin and Soft Tissue Substitutes
• Boniva
• Brachytherapy for Clinically Localized Prostate Cancer Using Permanently Implanted Seeds
• Brachytherapy for Treatment of Miscellaneous Cancers
• Breast Reconstruction/Removal and Replacement of Implants
• Cardiovascular Risk Panels
• Catheter Ablation as Treatment for Atrial Fibrillation
• Charged-Particle Radiotherapy for Neoplastic Conditions
• Clotting Factor Replacement Therapy
• Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate or Dermatologic Tumors
• Cryosurgical Ablation of Primary or Metastatic Liver Tumors
• Durable Medical Equipment (DME)
• Electric Tumor Treatment Fields
• Endobronchial Brachytherapy
• Entyvio
• Extracranial/Intracranial Bypass Surgery
• Fabrazyme
• Forteo Injection
• Genetic Testing and Counseling, Other
• Genetic Testing for Cytochrome p450 (CYP450) Variants
• Genetic Testing for JAK2, MPL and CALR Mutation Analysis in Myeloproliferative Neoplasms
• Genetic Testing for KRAS, NRAS and BRAF Variant Analysis in Metastatic Colorectal Cancer
• Genetic Testing for Li-Fraumeni Syndrome
• Genetic Testing for Mental Health Conditions
• Genetic Testing for Tamoxifen Treatment
• Genetic Testing for Warfarin Dose
• Genetic Testing in Fine Needle Aspirates of the Thyroid
• Genetic Testing With Genetic Panels
• Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
• Hereditary Angioedema Medication Therapy
• High-Dose Rate Temporary Prostate Brachytherapy
• Hormone Pellet Therapy
• Immunotherapy, Adoptive
• Implantable Bone-Conduction and Bone-Anchored Hearing Aids
• Implantable Neurostimulator for the Treatment of Central Sleep Apnea
• In Vitro Chemoresistance and Chemosensitivity Assays
• Interferential Current Stimulation
• Intracavitary Balloon Brachytherapy for Malignant and Metastatic Brain Tumors
• Intraoperative Radiation Therapy
• Intraperitoneal Chemotherapy, Cytoreduction
• Kevzara
• Krystexxa
• Laboratory Tests for Diagnosis and Mgmt of Inflammatory Bowel Disease
• Laser Interstitial Thermal Therapy (LITT)
• Laser Therapy
• Lutathera
• Mastectomy for the Treatment of Fibrocystic Breast Disease
• Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate
• Multitarget Polymerase Chain Reaction (PCR) Testing for Diagnosis of Bacterial Vaginosis
• NanoKnife
• Nucala
• Oscillatory Devices
• PathFinderTG Molecular Testing
• Pectus Deformity Repair
• Perjeta (pertuzumab) for Treatment of Malignancies
• Photodynamic Therapy for Treatment of Cancer
• Physical Therapy for Pelvic Floor Disorders
• Polysomnography for Non-Respiratory Sleep Disorders
• Prolia
• Radioembolization for Primary and Metastatic Tumors of the Liver
• Radiofrequency Ablation of Primary or Metastatic Liver Tumors
• Reclast
• Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
• Serum Protein Biomarkers for Breast Cancer
• Signifor (pasireotide) and Signifor LAR (pasireotide)
• Stem Cell Therapy for Peripheral Arterial Disease
• Stem Cell Therapy, Orthopedic Applications
• Tecentriq
• Testosterone Replacement Therapy
• Total Ankle Replacement
• Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies
• Transcranial Magnetic Stimulation of the Brain as Treatment for Depression and Other Psychiatric/Neurologic Disorders
• Treatments for Gender Dysphoria
• Tremfya
• Urine Drug Testing for Drug-Drug Interaction and Urine Specimen DNA Authentication Testing
• Wheeze Rate and Cough Monitoring Devices
• Xolair
• Zometa

Click here to view the Arizona Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.